Medicare Pay Cuts for Poor Readmission Scores Begin
He adds that quality is maintained by allowing employees to see those results on a monthly basis. "We know if we're doing things right, those scores take care of themselves." He adds that Lincoln perhaps has an advantage because it is physician-owned, "and from a quality standpoint, it's easy for us to work with physicians because they have a vested interest in the outcome."
One element of note is that according to the "dry run" statistics listing the best performing VBP hospitals, nearly all are small hospitals or specialty hospitals, with no more than 30 beds. And that holds true for the top performing readmission hospitals too.
Weil says that new measures are being applied to the formula in coming years, and with those new measures will come a different lineup of winners and losers, especially as the formula that determines best and worst is adjusted.
"We believe the results are equitable in that about the same number of hospitals win versus lose," he says. "However, we need to watch carefully over time to determine if particular classes of hospitals, such as (those providing care as part of) the safety net, are disproportionately penalized."
Of course, for both the value-based purchasing incentive payments and readmissions penalties, stakes rise next year based on new, and more up-to-date, performance periods. For readmissions, the penalty increases to up to 2%. And the value-based purchasing incentive pool grows from 1% of Medicare base DRG to 1.25%
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- 4 Tips for Managing Employed Physicians
- WellPoint Dominates Nearly Half of Markets, AMA Says
- Defensive Medicine Still Prevalent Despite Tort Reform
- CMS Offers Some ACOs $114M for 'Upfront' Costs